Highland Capital Management (Texas)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Highland Capital Management (Texas)’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,400	Closed	-$843K	–	387
2019 Q1	$843K	Buy	+7,400	New	+$544K	0.05%	218
2017 Q4	–	Sell	-45,000	Closed	-$4.01M	–	362
2017 Q3	$4.01M	Buy	45,000 +4,700	+12%	+$357K	0.18%	112
2017 Q2	$2.41M	Sell	40,300 -30,700	-43%	-$1.72M	0.1%	132
2017 Q1	$3.79M	Sell	71,000 -41,000	-37%	-$2.43M	0.19%	115
2016 Q4	$5.59M	Buy	+112,000	New	+$6M	0.26%	93
2015 Q4	–	Sell	-266,059	Closed	-$11.1M	–	308
2015 Q3	$11.1M	Buy	266,059 +208,582	+363%	+$10.9M	0.32%	91
2015 Q2	$3.46M	Buy	+57,477	New	+$3.8M	0.07%	174

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Highland Capital Management (Texas)'s ONCE Position: Q2 2019 in Review

Highland Capital Management (Texas) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 7,400 shares — an estimated $843K sold.

Highland Capital Management (Texas) first reported a position in ONCE in Q2 2015 and held it in 7 quarters. The position peaked at $11.1M in Q3 2015. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

Highland Capital Management (Texas) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Highland Capital Management (Texas) sold 7,400 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $843K.
Highland Capital Management (Texas) first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 7 quarters.
Highland Capital Management (Texas)'s Spark Therapeutics, Inc. Common Stock position peaked at $11.1M in Q3 2015.
194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.